CD BioGlyco Launches Targeted Antibody Deglycosylation Services to Advance Biopharmaceutical Research
CD BioGlyco, a leading provider of glycosylation-related services, is proud to announce the launch of its specialized antibody deglycosylation services, including Hydrolysis of All Fc-Glycans and Hydrolysis of Complex-Type N-Glycans. These services are designed to help pharmaceutical and biotechnology companies better understand and optimize the role of glycosylation in therapeutic...
0 Comments 0 Shares